Navigation Links
SGX Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2007
Date:11/13/2007

ET program, with submission of the SGX523 IND now expected to take place ahead of schedule," said Mike Grey, President and Chief Executive Officer. "We are continuing to evaluate partnering opportunities for our MET program and remain committed to maximizing the value of this program for SGX and its stockholders while concurrently focusing our energies on submitting the IND in 2007 and initiating clinical studies of SGX523 in early 2008."

Financial Results for the Three and Nine Months Ended September 30, 2007

Total revenues for the three months ended September 30, 2007 were $7.6 million, compared to $6.8 million for the three months ended September 30, 2006. Total revenues for the nine months ended September 30, 2007 were $27.1 million, compared to $19.3 million in the nine months ended September 30, 2006. The increase of $0.8 million for the three month period was primarily attributable to additional revenues associated with the additional expenditures incurred in connection with our federal research grant and additional services provided under other commercial agreements. The increase of $7.8 million for the nine month period was primarily due to additional revenue earned through our collaboration with Novartis, together with the achievement of a milestone, and additional services provided, under other commercial agreements. The increase for the nine month period ended September 30, 2007 also reflects the recognition of revenue in the first quarter of 2007 related to the reimbursement of overhead costs incurred on grant research efforts since the commencement of the grant in July 2005.

Research and development expenses for the three months ended September 30, 2007 and 2006 were $10.5 million and $8.6 million, respectively. Research and development expenses for the nine months ended September 30, 2007 and 2006 were $31.0 million and $35.6 million, respectively. The increase of $1.9 million for the three month period was primarily attributable to
'/>"/>

SOURCE SGX Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... ... July 04, 2015 , ... Chronic Neck Pain. Neck pain is ... located in the neck. Another 19% suffer from head, migraine, or facial pain, in ... that 45% of American workers must deal with neck pain. Strategies for ...
(Date:7/3/2015)... ... July 03, 2015 , ... On June ... a new SEO training system called "Page One Engine" . The program, ... has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. ... been retained to lead a national chief nursing officer recruitment for ... firms in the healthcare industry, B. E. Smith has recently placed more than ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... First ... United States, named Mariah N. Manzanares, MD as the new Medical Director of its ... facility medical director of our Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:7/2/2015)... , ... July 02, 2015 , ... sweetFrog Enterprises, LLC. ... The opening is the first sweetFrog store located in Mississippi. The premium frozen yogurt ... in 2014. , The store, located at 104 Railroad Avenue, New Albany, MS 38652, ...
Breaking Medicine News(10 mins):Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:sweetfrog Opens First Location in Mississippi 2
... News) -- Over the last decade, the number of ... a smaller slice of the 10-year hospitalization rate than ... finding stems from the largest effort launched in the ... patterns. In the latest year, Medicare hospitalizations totaled about ...
... University of Houston (UH) students, two from the ... College of Social Work (GCSW), will lead health-related ... 2011-2012 under the Houston-Galveston Schweitzer Fellows Program. ... program sites throughout the U.S., the newly selected ...
... Calif. Evolutionary geneticist John H. Werren will give ... Riverside on Monday, May 16. His lecture, titled "Using ... speciation," will take place at 4 p.m. in the Genomics Auditorium, ... 5 p.m. in the Department of Entomology lobby. Both ...
... (HealthDay News) -- ,Bedbugs carrying two types of drug-resistant ... discovery in light of the resurgence of bedbugs in ... years. The researchers tested five bedbugs collected from ... Columbia known as Downtown Eastside, which has high rates ...
... News) -- The flakes of human skin in household dust ... Humans shed their entire outer layer of skin every ... study, published in the May issue of the journal ... oils such as cholesterol and squalene, are a major contributor ...
... exercise all have received their fair share of blame for ... to a University of Illinois researcher, public health enemy No. ... one staple of modern life most Americans can,t seem to ... Jacobson, a professor of computer science and the director of ...
Cached Medicine News:Health News:Fewer Medicare Patients Hospitalized for Heart Trouble 2Health News:3 University of Houston students chosen as Albert Schweitzer Fellows 2Health News:Evolutionary geneticist to give talk at UC Riverside on how biological species evolve and adapt 2Health News:Bedbugs May Transmit Drug-Resistant Bacteria 2Health News:Shed Skin in Dust May Reduce Indoor Air Pollution 2Health News:Study: Surge in obesity correlates with increased automobile usage 2Health News:Study: Surge in obesity correlates with increased automobile usage 3Health News:Study: Surge in obesity correlates with increased automobile usage 4
(Date:7/2/2015)...   EVO Aesthetic Center and Wellness Spa ... aesthetics in Lakeway, Texas and ... Astanza Duality laser. The medical spa is focused on ... and laser procedures. Their addition of the Astanza Duality ... to their tattoo regret. "The large number ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 ... of assets related to the ion channel biology platform ... previously been obtained as part of Pfizer,s 2011 acquisition ... Pfizer,s rights to the "Icagen" name and trademark.  XRPro ... comprehensive services for ion channel and transporter drug discovery, ...
(Date:7/2/2015)... , 2 de julio de 2015 ... ADN de alto rendimiento en ... American College of Pathologists (CAP). La instalación de BGI en ... laboratorio de secuenciación de próxima generación que recibe la ... el más alto estándar en prácticas de laboratorio clínico. ...
Breaking Medicine Technology:EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4BGI recibe la acreditación del College of American Pathologists (CAP) 2
Multi-constituent Calibration Plasma for Functional Assays of Coagulation Parameters on STA© Analyzers....
Multi-constituent normal and abnormal plasma controls for routine and specialty assays performed on the STA© family of hemostasis analyzers....
... Normal and Abnormal Control ... of vWF, D-dimer and ... STA© Analyzers. For use ... (#0518),STA© LIATEST© D-DI (#0515) ...
ApolipoproteinA-1 & B Calibrator...
Medicine Products: